Composite diffuse large B-cell and peripheral T-cell lymphoma with T-helper phenotype treated with both rituximab and brentuximab vedotin

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2021-11, Vol.100 (11), p.2873-2875
Hauptverfasser:	Ohya, Kouichi, Okuyama, Shuhei, Ogata, Shin-ya, Maeda, Kunihiko, Yamada, Kyohei, Ohshima, Kouichi, Tajima, Katsushi
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged, 80 and over Antineoplastic Agents, Immunological - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Brentuximab Vedotin - therapeutic use Female Hematology Humans Letter to the Editor Lymphoma, Large B-Cell, Diffuse - complications Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, T-Cell, Peripheral - complications Lymphoma, T-Cell, Peripheral - drug therapy Medicine Medicine & Public Health Oncology Rituximab - therapeutic use T-Lymphocytes, Helper-Inducer - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!